Abstract
Allergic rhinitis is one of the most widespread human diseases. The article presents the modern classification of allergic rhinitis, the main approaches to treatment. The indications for carrying out hyposensitizing therapy for this disease have been determined, the effectiveness of nonspecific hyposensitizing therapy, conducted with the antihistamines of the second generation, which have a high affinity for H1 receptors. Also demonstrated the possibilities of the original drug bilastin (Nixar) – a representative of a group of antihistamines.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
